Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Hematologic Neoplasms × veliparib × Clear all

Sponsor

Conditions

Breast Neoplasms 7 Triple Negative Breast Neoplasms 4 Ovarian Neoplasms 4 Glioblastoma 4 Small Cell Lung Carcinoma 3 Neoplasm Metastasis 3 Gliosarcoma 3 Fallopian Tube Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Astrocytoma 3 Rectal Neoplasms 2 Pancreatic Neoplasms 2 Lymphoma, T-Cell 2 Lymphoma, Mantle-Cell 2 Glioma 2 Colorectal Neoplasms 2 Brain Neoplasms 2 Waldenstrom Macroglobulinemia 1 Uterine Cervical Neoplasms 1 Thrombocythemia, Essential 1 Squamous Cell Carcinoma of Head and Neck 1 Skin Neoplasms 1 Sezary Syndrome 1 Prostatic Neoplasms 1 Primary Myelofibrosis 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Polycythemia Vera 1 Oropharyngeal Neoplasms 1 Oligodendroglioma 1

Interventions

Cyclophosphamide 34 fludarabine 25 fludarabine phosphate 24 Tacrolimus 24 Mycophenolic Acid 23 Whole-Body Irradiation 22 Busulfan 15 Methotrexate 12 Melphalan 12 Granulocyte Colony-Stimulating Factor 12 Antilymphocyte Serum 12 thymoglobulin 11 Cyclosporine 11 Stem Cell Transplantation 10 Filgrastim 10 Rituximab 9 Thiotepa 7 Peripheral Blood Stem Cell Transplantation 7 Nivolumab 7 Dexamethasone 7 Radiotherapy 6 Mesna 6 Cytarabine 6 trametinib 5 Prednisone 5 Calcium Dobesilate 5 Bortezomib 5 Azacitidine 5 Alemtuzumab 5 Voriconazole 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡